View Archive: 2008  |  2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000  |  1999  |  1998

December 16, 2004
Cytokinetics Announces the Initiation of an Additional Phase II Clinical Trial for Lead Cancer Drug Candidate

December 8, 2004
Cytokinetics Presents Research Data from Heart Failure Program

November 30, 2004
Cytokinetics Announces Eleven Abstracts to be Presented at the 44th annual American Society of Cell Biology Meeting

November 23, 2004
Cytokinetics to Present at the Lazard Life Sciences Conference

November 11, 2004
Cytokinetics to Present at the Credit Suisse First Boston Annual Healthcare Conference

November 8, 2004
Cytokinetics Announces Data from Heart Failure Drug Discovery Program Presented at the 2004 Scientific Sessions of the American Heart Association

November 2, 2004
Cytokinetics Announces Research Data from Heart Failure Program at the American Heart Association Annual Meeting

October 22, 2004
Cytokinetics to Present at the Rodman and Renshaw Conference

October 21, 2004
Cytokinetics, Incorporated Reports Third Quarter Financial Results

October 14, 2004
Cytokinetics to Announce Third Quarter Results on October 21, 2004

October 7, 2004
Cytokinetics to Present at the BIO Emerging Company Investor Forum Conference

July 28, 2004
Cytokinetics, Incorporated Reports Second Quarter Financial Results

July 23, 2004
Cytokinetics to Present at the Banc of America Securities Specialty Pharmaceuticals Conference

July 21, 2004
Cytokinetics to Announce Second Quarter Results on July 28, 2004

June 16, 2004
Cytokinetics, Incorporated Reports 2004 First Quarter Financial Results

June 10, 2004
Cytokinetics to Present at the Third Annual Needham Biotechnology Conference

June 9, 2004
Cytokinetics to Announce First Quarter Results on June 16, 2004

June 8, 2004
Cytokinetics to Present at Pacific Growth Equities’ Life Sciences Growth Conference

June 7, 2004
Cytokinetics Announces Phase I Results for SB-715992 presented at the 2004 Annual Meeting Of The American Society of Clinical Oncology

June 3, 2004
Cytokinetics to Present at Goldman Sachs Twenty Fifth Annual Global Healthcare Conference

June 2, 2004
Cytokinetics Announces Phase I Results for SB-715992 to be Presented at the 2004 Annual Meeting Of The American Society of Clinical Oncology

May 27, 2004
Cytokinetics to Present at Friedman, Billings, Ramsey’s 8th Annual Growth Investor Conference

May 17, 2004
Cytokinetics to Present at Bank of America Securities Health Care Conference

May 13, 2004
Cytokinetics Announces the Initiation of Phase I Clinical Trial for SB-743921 in Cancer Patients with Solid Tumors

May 4, 2004
Cytokinetics, Incorporated Announces Closing of its Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares

May 3, 2004
Cytokinetics Publication in Cancer Research Demonstrates Antitumor Activity of a Kinesin Spindle Protein (KSP) Inhibitor in a Preclinical Model

April 29, 2004
Cytokinetics, Incorporated Announces Its Initial Public Offering

January 27, 2004
Cytokinetics, Inc. Files for Initial Public Offering

January 14, 2004
Cytokinetics Announces the Initiation of a Broad Phase II Clinical Trials Program in Oncology for SB-715992